Winthrop Advisory Group LLC Abb Vie Inc. Transaction History
Winthrop Advisory Group LLC
- $828 Million
- Q1 2025
A detailed history of Winthrop Advisory Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Winthrop Advisory Group LLC holds 3,105 shares of ABBV stock, worth $539,586. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,105
Previous 4,494
30.91%
Holding current value
$539,586
Previous $798,000
18.55%
% of portfolio
0.08%
Previous 0.09%
Shares
19 transactions
Others Institutions Holding ABBV
# of Institutions
4,153Shares Held
1.29BCall Options Held
17MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$30.1 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$13.8 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$9 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$6.9 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $307B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...